Berkeley SkyDeck

Drill Surgeries is a company dedicated to enhancing the outcomes of trauma and orthopedic surgeries through its innovative AI-powered navigation system. This technology aims to significantly reduce the failure rate of surgeries from 36% to less than 4% by providing real-time guidance during osteosynthesis procedures. By employing proprietary AI algorithms and mixed reality technologies, Drill Surgeries facilitates a remarkable 83% reduction in operating room time. Additionally, the company’s solutions eliminate the need for unnecessary X-rays, leading to substantial cost savings of approximately $2,000 per operation for hospitals. Through these advancements, Drill Surgeries empowers doctors to perform complex procedures more efficiently and effectively, ultimately improving patient care and operational efficiency in healthcare settings.

We are an innovative AI-driven digital pathology company, dedicated to shaping the future of diagnostics and research, with a mission to empower accurate diagnoses and elevate patient care globally.

Okomera is a biotech start-up focused on enhancing access to more effective, precision-based cancer therapies. The company has pioneered the automation and miniaturization of individualized tumor biopsy research, developing advanced medical technologies that leverage microfluidic 3D cellular assays. These innovative technologies enable the prediction of patient-specific responses to cancer treatments by automating relevant biopsy testing. In this process, tumor cells are cultivated within thousands of microfluidic droplets and exposed to numerous conditions simultaneously. This approach allows healthcare providers to expedite the development and delivery of modern cancer therapies, ultimately improving treatment outcomes for patients.

MZR Neurotech is a medical technology company focused on sleep monitoring solutions. The company has developed an innovative in-ear electroencephalogram (EEG) sensor that utilizes biosensors to accurately measure brain activity during sleep. This device allows users to enhance their sleep quality by providing valuable insights into their sleep patterns. By leveraging cutting-edge technology, MZR Neurotech aims to contribute to better sleep health and understanding.

Gisens Biotech is a biotechnology company focused on bioelectronics and nanotechnology, developing portable diagnostics such as the Nano-Lab, a device that provides real-time measurements of biomarkers from tiny samples of blood, urine, or saliva. The Nano-Lab aims to deliver accurate, portable biomarker analysis and interpretation, potentially changing how measurements are performed. The company is also pursuing a nanotechnology-based platform to diagnose and monitor renal biomarkers—urea, creatinine, and potassium—from a single blood drop, with results accessible through an application for real-time health monitoring.

Music Health develops digital music-based solutions to support mental health and wellbeing, aiming to make music therapy accessible and affordable. Its Vera product targets dementia care, helping manage behavioral and psychological symptoms of dementia for about 60 million individuals living with dementia and almost 200 million carers. The company also offers a mood-based music application with a patented playlist generator and discovery tool that enables users to create genre- and mood-driven playlists for activities such as parties, commuting, or dynamic environments in retail and office settings.

GenomeUp is a Rome-based healthtech startup that specializes in AI-powered solutions for genetic analysis and clinical decision support. The company aims to serve as a global reference platform to enhance clinical decision-making for hospitals, laboratories, research centers, and pharmaceutical companies. By providing tools that accelerate diagnosis times and improve patient care, GenomeUp seeks to deliver actionable insights for health prevention within a 24-hour timeframe. Emphasizing its commitment to social responsibility, the company has evolved into an Italian Benefit Corporation, prioritizing sustainable and transparent practices that consider the well-being of stakeholders, communities, and the environment.

CenSyn develops a portable brain health assessment platform. It comprises a handheld EEG device for rapid neurological evaluation, a mobile app for real-time data viewing, and machine learning algorithms to detect mental status changes. This enables medical professionals to conduct cognitive assessments across various settings.

DeepScribe develops an AI-powered platform that automates medical note-taking for clinicians. Its solution captures and transcribes clinical conversations in real-time, extracts relevant information, and integrates notes into electronic health records (EHR). DeepScribe enables healthcare providers to focus on patient care while reducing documentation burden.

Women aged 20-45 cannot get screened for breast cancer because existing solutions are unreliable. However, 81% want to. At The Blue Box, we have built a pain-free, low-cost, sensitive, radiation-free device to detect breast cancer in urine with a sensitivity of 83%. In 2024, we’ll launch into the market, bringing The Blue Box to private gynecology clinics with a Diagnostics-as-a-Service subscription model, and a pay-per-test revenue stream that we’ll share with doctors.

Appa Health is a digital mental health management platform aimed at addressing the mental health crisis among teenagers. The company provides accountability to ensure that teens engage with its video-based courses of care and apply the skills they learn. Appa Health connects teens with relatable near-peer mentors, fostering a supportive environment that encourages young individuals to prioritize their mental well-being. The platform integrates research-backed therapeutic methods alongside care navigation specialists and therapists, offering personalized support tailored to each teen's needs. By focusing on relatable connections and accessible resources, Appa Health seeks to empower adolescents to take proactive steps in managing their mental health.

Founded in 2017, ImmunoMind develops an AI-based platform that enhances drug discovery using single-cell immunogenomics technologies. Its products include Immunarch AI for precision drug discovery and Immunarch, an open-source R package for bioinformatics explorations.

Aesop Technology is a developer of artificial intelligence solutions focused on reducing prescription-related errors and enhancing patient safety. Founded in 2019 and based in Berkeley, California, the company offers MedGuard, an AI-enhanced safety system that supports various aspects of prescription management, including prescribing, dispensing, administering, and compliance services. Aesop Technology also provides a clinical decision support system that assists healthcare providers by flagging inappropriate prescriptions based on patient diagnosis, age, and gender. By leveraging machine learning, the company's technology aims to improve healthcare quality and safety while streamlining billing-related documentation, ultimately enhancing patient safety and the accuracy of medical billing.

Acunon develops medical diagnostic devices that offer vitro tests for STD patients. The company makes it convenient and accessible for low-income consumers, women, the LGBTQ+ community, and the elderly. Acunon Health is headquartered in Berkeley, California.

Aila Health is a virtual precision health clinic focused on addressing the needs of the approximately 50 million Americans living with autoimmune diseases, with a significant majority being women. Founded in 2020 and headquartered in San Francisco, California, the company leverages a data-driven platform that integrates patient information to support integrative care teams in delivering personalized, multi-specialty care. Aila Health's clinical platform offers access to specialists, health coaches, personalized nutrition, patient education, and remote monitoring devices. By facilitating seamless remote patient monitoring, the platform enables healthcare providers to tailor care management to each patient's unique health history, genetic profile, lifestyle, and environment, ultimately improving health outcomes and reducing costs.

Root Applied Sciences Inc. is a precision pathogen management company that specializes in automated DNA-based sensors designed for monitoring airborne pathogens. Founded in 2018 by Sarah Placella, the company is headquartered in Oakland, California. Its technology collects airborne particles and analyzes their DNA to quantify the presence of pathogens, enabling farmers to apply pesticides at optimal times. This approach allows agricultural growers to be proactive in disease management, promoting sustainability, reducing costs, and minimizing environmental impact. Root Applied Sciences offers its monitoring services through a subscription model, providing alerts directly to users' phones or automatically uploading data to a centralized dashboard for efficient decision-making.

Clinic Price Check provides hospital price comparisons to help consumers choose lower-cost health providers. The service offers price data for thousands of services across 350+ California hospitals, enabling users to compare costs and select more economical options. Its platform aggregates public data from hospitals, the Centers for Medicare and Medicaid Services and other public sources to deliver price transparency and foster competition in healthcare. Founded in 2019 by Joanne Rodrigues and based in Santa Clara, California, Clinic Price Check focuses on empowering consumers with actionable pricing information.

DeepRed Technologies, founded in 2019 by Chase Chen, Sanjay Rao, Junqiao Wu, and Kechao Tang, specializes in developing advanced thermal imaging technology aimed at improving the thermal sensitivity of various thermal cameras. The company utilizes phase transition materials with engineered microstructures to enhance temperature resolution, which enables applications across multiple sectors, including healthcare, energy, manufacturing, and artificial intelligence. One of its notable projects focuses on a safer and more accurate breast cancer screening method. Additionally, DeepRed's technology supports a range of uses such as musculoskeletal imaging, integrated circuit inspection, and equipment evaluation, showcasing its versatility and commitment to innovation in critical fields.

DiffZero is a platform that facilitates rehabilitation and training for coaches, athletes, and patients. It specializes in providing support services for ACL rehabilitation, aiming to enhance outcomes for both patients and healthcare professionals. The company offers an interactive and personalized rehabilitation experience grounded in evidence-based practices. Its innovative use of vision technology allows for detailed insights into movement tests, which helps clinicians provide superior care while enabling patients to effectively reach their fitness goals.

Founded in 2015, mFluiDx specializes in manufacturing diagnostic chips that enable molecular detection for infectious disease diagnosis. Their innovative technology aims to provide rapid, affordable, and field-deployable diagnostics.

AHEAD Medicine is a health-tech company focused on advancing cancer precision medicine through AI-enabled immunoprofiling diagnostics. Its flagship product, the AHEAD-flow platform, is an innovative machine learning-based tool that automates clinical cytometry analysis for blood cancer patients, significantly enhancing the speed of diagnosis compared to traditional methods. By streamlining the data analysis workflow, AHEAD Medicine aims to improve the efficiency, reproducibility, and scalability of diagnostic services for blood-related diseases. The company is actively engaged in co-development projects with pharmaceutical firms to create companion diagnostics in immuno-oncology. Currently, AHEAD Medicine is seeking funding to establish a quality management system, complete FDA pre-submission processes, and initiate external validation studies for its AHEAD-flow platform.

GenomeUp is a Rome-based healthtech startup that specializes in AI-powered solutions for genetic analysis and clinical decision support. The company aims to serve as a global reference platform to enhance clinical decision-making for hospitals, laboratories, research centers, and pharmaceutical companies. By providing tools that accelerate diagnosis times and improve patient care, GenomeUp seeks to deliver actionable insights for health prevention within a 24-hour timeframe. Emphasizing its commitment to social responsibility, the company has evolved into an Italian Benefit Corporation, prioritizing sustainable and transparent practices that consider the well-being of stakeholders, communities, and the environment.

GenomEdge is a biotechnology company based in Berkeley, California, that specializes in providing DNA testing services. Founded in 2019, the company focuses on utilizing genetic information to enhance health and wellness outcomes for individuals. By leveraging advancements in biotechnology, GenomEdge aims to deliver precise and actionable insights derived from DNA analysis, catering to a growing demand for personalized health solutions.

CredibleMind is a digital platform that provides self-care resources and navigation for mental health, emotional wellbeing, and spiritual growth. The platform offers curated content and tools on topics such as anxiety, depression, stress, sleep, and meditation, accessible via a website and mobile app. It aggregates tens of thousands of resources from experts and uses AI to help users identify high-quality information and approaches that may work for them. The company emphasizes evidence-based guidance and the practical goal of helping individuals optimize their mental health, often complementing professional care. CredibleMind collaborates with researchers and clinicians and serves individuals as well as organizations such as employers, insurers, healthcare providers, and health departments that support mental wellbeing initiatives.

Taiwan User-Friendly Sensor & Tech is a company focused on addressing food safety challenges, particularly concerning food allergens. Based in China, it develops innovative IoT systems designed for on-site detection of food allergens. The company offers a multi-channel commercial detection module targeted at food processing industries, restaurants, and hypermarkets, as well as a portable device intended for personal use. With a high level of sensitivity, these products provide accurate and detailed information about allergens in food within just two minutes, empowering users to make informed dietary choices.

Vision Science Labs, Inc. is a software company based in Palo Alto, California, specializing in digital tools for the healthcare sector, particularly in vision care. Established in 2017, the company has developed a comprehensive platform for vision therapy that facilitates remote training and assessment for clinicians and patients. Its system allows healthcare providers to assign and monitor vision therapy exercises, enabling effective online management of visual conditions. The platform is designed to enhance patient access to vision care services and supports early detection and treatment of visual conditions related to various diseases in optometry and ophthalmology. Vision Science Labs aims to expand its digital tool offerings beyond eye care into areas such as neurology and physical therapy.

Dieta Health operates a healthcare technology platform and mobile application that provides personalized digestive health recommendations for individuals with Irritable Bowel Syndrome. The platform collects high‑resolution data on users’ diet, bowel movements, medications, and other factors, aggregates insights across a broad user network, and uses machine learning to tailor recommendations to each user’s path toward symptom relief and improved quality of life.

Serinus Labs, Inc. is a manufacturer of nano-scale silicon gas sensors, established in 2017 and based in Berkeley, California. The company specializes in developing integrated chip-scale gas sensors tailored for various industries, including health and safety, automotive, consumer electronics, and healthcare. Serinus Labs offers custom solutions that address both existing and emerging market needs. In particular, the company focuses on providing ultra-low-power trace gas sensors for Li-ion battery state-of-health monitoring, which enhances battery intelligence in electric vehicles. Through its innovative technology, Serinus Labs aims to meet critical demands across strategic markets.

SynderBio, Inc. is a biotechnology company based in Coralville, Iowa, founded in 2016. It specializes in developing advanced cell separation techniques aimed at enhancing cancer diagnosis and single-cell sequencing. The company's patented technology facilitates the isolation and enrichment of cancer cells from biopsy samples, which is critical for precision cancer medicine. By providing a rapid and label-free approach, SynderBio's methods improve the efficiency of processing mixed biological specimens, thereby enabling researchers and clinicians to more accurately identify genomic markers associated with cancer. This innovation supports timely diagnosis and treatment options, ultimately benefiting oncologists, pathologists, and patients alike.

Medostic, Inc. is a digital therapeutics company headquartered in San Francisco, California, founded in 2017 by Michael Horning and George Brooks. It specializes in developing proprietary integrated inpatient clinical decision support software that personalizes metabolic treatment for critical care patients. The company's solutions focus on improving glycemic control and addressing other critical health indicators by utilizing measurements of glucose, lactate, and various metabolites related to the body's energy state. Medostic's innovative closed-loop systems employ proprietary algorithms to tailor infusion administration of therapeutic formulations, thereby enhancing the management of metabolic and nutritional needs in critically ill patients.

DeepScribe develops an AI-powered platform that automates medical note-taking for clinicians. Its solution captures and transcribes clinical conversations in real-time, extracts relevant information, and integrates notes into electronic health records (EHR). DeepScribe enables healthcare providers to focus on patient care while reducing documentation burden.

AHEAD Medicine is a health-tech company focused on advancing cancer precision medicine through AI-enabled immunoprofiling diagnostics. Its flagship product, the AHEAD-flow platform, is an innovative machine learning-based tool that automates clinical cytometry analysis for blood cancer patients, significantly enhancing the speed of diagnosis compared to traditional methods. By streamlining the data analysis workflow, AHEAD Medicine aims to improve the efficiency, reproducibility, and scalability of diagnostic services for blood-related diseases. The company is actively engaged in co-development projects with pharmaceutical firms to create companion diagnostics in immuno-oncology. Currently, AHEAD Medicine is seeking funding to establish a quality management system, complete FDA pre-submission processes, and initiate external validation studies for its AHEAD-flow platform.

Fiat Lux Laboratories is a Biotechnology that develops a Biochemical Processing Sensor. The company was founded in 2017 by Yash Shah and is based in Berkeley, California.

Pinpoint Science, Inc. is a San Francisco-based company focused on developing innovative bio-electronic diagnostics for the rapid detection, diagnosis, and surveillance of infectious diseases globally. Established in 2015, the company has created a diagnostics device that utilizes advanced nanosensor technology. This device employs swappable cartridges to identify pathogens, including viruses, bacteria, and fungi, in various biofluids such as blood and saliva. By enabling label-free electrical detection of specific biomolecules, Pinpoint Science aims to enhance the accuracy and cost-effectiveness of infectious disease diagnostics, ultimately transforming the healthcare sector's approach to disease management.

Blumio, Inc. is a healthcare technology company based in San Francisco, California, founded in 2014. The company specializes in the development of a non-invasive radio frequency wearable sensor designed to measure blood pressure and other cardiovascular diagnostics. Unlike traditional methods that rely on inflatable cuffs, Blumio's sensor utilizes radar technology to detect and analyze the pressure waves traveling through blood vessels, enabling continuous and accurate monitoring of blood pressure throughout daily activities. This innovative approach allows users to track their cardiovascular health in real-time, providing insights that traditional devices cannot offer. By focusing on the dynamic nature of blood pressure and its variations based on activity, Blumio aims to enhance the way individuals monitor their vitals and improve overall health and wellness.

Memora Health is a San Francisco-based healthcare technology company that develops an intelligent care enablement platform to automate outpatient communication and digital workflows. The platform helps clinicians focus on top-of-license practice by digitizing and triaging patient-reported concerns and data, enabling proactive two-way communication and support for patients along complex care journeys, and it partners with health systems, health plans, and digital health companies to transform care delivery for care teams and patients.

DotLab is a women's healthcare technology company focused on the diagnosis of endometriosis. It has developed a non-invasive diagnostic tool that utilizes biomarkers and machine learning to identify active endometriosis. This innovative approach addresses the complexities associated with the disease's heterogeneity by employing a multi-analyte, algorithmic strategy. Through its technology, DotLab aims to enable early diagnosis and facilitate timely treatment for women suffering from endometriosis, thereby transforming the management and understanding of the condition.

Nosocom Solutions focuses primarily on the development of technology solutions to prevent and reduce Healthcare-Associated Infections (HAI). The company was established in 2012 founded by Naresh Sunkara.

Lioness is a company focused on empowering women through innovative sexual wellness products. It develops an adaptive vibrator equipped with biometric sensors, designed to help women understand and take control of their bodies. This vibrator is paired with an application that allows users to visualize physiological responses and access a supportive community for personalized advice. By utilizing advanced technology, Lioness enables women to gain insights into their sexuality, including arousal patterns and optimal timing for sexual experiences. The company emphasizes a women-centric approach, with leadership and design choices reflecting the needs and preferences of women. By utilizing materials commonly used in medical devices and ergonomics tailored for comfort, Lioness aims to change the conversation surrounding female sexuality and provide valuable tools for self-discovery and empowerment.

Kryptos Biotechnologies, Inc. is a biotechnology company that specializes in developing innovative life science tools aimed at enhancing the understanding of biological complexities for clinicians and scientists. Founded in 2017 by Jinyong Lee and Jun Ho Son, and headquartered in Hayward, California, the company focuses on molecular diagnostic software for the rapid diagnosis of infectious diseases. Kryptos Biotechnologies offers a unique platform featuring an ultrafast photonic polymerase chain reaction (PCR) technology. This system utilizes photothermal heating and plasmonic thin films powered by light-emitting diodes, allowing medical professionals to make timely clinical decisions at a cost-effective rate.

Karuna Labs Inc. specializes in the development of digital therapeutics programs aimed at addressing chronic pain. The company employs a unique approach that combines physical and cognitive retraining to help individuals manage their pain. Its platform utilizes targeted sensorimotor incongruences to deliver comprehensive programs that include physical therapy, pain psychology, cognitive neuroscience, and functional restoration. By offering these innovative solutions, Karuna Labs enables clinics, individuals, and research institutions to effectively treat chronic pain through virtual embodiment training, enhancing the rehabilitation process and improving patient outcomes.

InkSpace Imaging, Inc. is a company focused on developing innovative magnetic resonance imaging (MRI) receive coils, particularly designed for pediatric patients. Founded in 2016 and based in Pleasanton, California, the company aims to enhance the MRI experience by creating ultra-lightweight, customizable coils that contour to the body, providing maximum image quality and reducing the necessity for general anesthesia during exams. These specially designed coils facilitate a more comfortable experience for young patients while also enabling MRI operators to improve efficiency and decrease costs through faster setup times and improved patient comfort.

Vivoo is a wellness company that offers personalized nutrition and lifestyle advice through its application. It uses weekly at-home urine tests to track parameters such as vitamin C, magnesium, calcium, salinity, oxidative stress, hydration, ketones, and protein, empowering users to understand their bodies and make healthier choices.

ResultCare, Inc., established in 2013 and headquartered in San Francisco, California, operates within the healthcare industry as an AI-driven clinical informatics and data analytics company. Founded by physicians and scientists from UCSF, ResultCare focuses on enhancing medical decision-making by providing a collaborative platform that eliminates uncertainties in clinical practices. The company has developed one of the largest clinical databases globally, leveraging machine learning and natural language processing to facilitate an evidence-based approach in identifying optimal and cost-effective laboratory and diagnostic tests. ResultCare's platform supports healthcare providers by utilizing real-time research data to improve the reproducibility of medical practices and to identify trends that help optimize care delivery, ultimately aiming to enhance patient outcomes while controlling costs.

Darmiyan develops a SaaS platform, BrainSee, for early detection and monitoring of neurodegenerative diseases like Alzheimer's. Using standard MRI scans and cognitive tests, BrainSee generates detailed brain maps and scores indicating neurodegeneration, enabling timely diagnosis and intervention.

Genomelink operates a digital genetic analysis platform that lets individuals upload their raw DNA data to generate reports on traits, wellness, ancestry, and nutrition. The service translates genomic information into user-friendly interpretations for personal exploration and genetic self-knowledge. It emphasizes data privacy by upholding user ownership of data, implementing ISO-certified security, and offering options to delete data. The company positions itself as a consumer-focused provider of accessible, detailed genomic insights, supporting informed health and lifestyle decisions while ensuring control and transparency over personal genetic information.

SwiftMotion is a company that specializes in developing wearable sensors and analytics aimed at enhancing the health and safety of industrial workers. The company's innovative ergonomic systems utilize full-body motion capture technology to conduct precise ergonomic risk assessments, while also capturing load and force data to identify potential risks. By offering these insights, SwiftMotion enables clients in sectors such as warehousing, distribution centers, airport transit, automotive, and insurance to design effective interventions that reduce injury rates. This not only promotes worker well-being but also helps organizations decrease costs associated with workers' compensation.

Angilytics is a company focused on cardiovascular wellness through the development of a wearable wristband that provides essential health metrics, including blood pressure and heart rate. Utilizing a patented sensor fusion technology combined with machine learning algorithms, the wristband enables healthcare professionals to remotely monitor patients with various cardiovascular conditions such as heart failure, atrial fibrillation, and myocardial infarction. By facilitating timely and informed medical interventions, Angilytics aims to reduce hospital readmission rates and lower overall healthcare costs, making it easier for doctors to manage and treat heart diseases efficiently.

Cocoon Cam is a technology company based in Silicon Valley that specializes in remote health monitoring through innovative computer vision technology. Its flagship product is a groundbreaking baby monitor that passively collects video feeds to analyze vital signs, providing parents with real-time alerts and historical data on their baby's breathing, movement, and future metrics such as heart rate and temperature fluctuations. This non-invasive approach distinguishes Cocoon Cam from traditional baby monitoring solutions, as it requires no wires or wearable devices. By leveraging cloud-based data analysis, the company empowers parents with instant access to critical health information about their children, ensuring peace of mind without compromising comfort.

Telelytics is a provider of a telemedicine platform that focuses on enhancing healthcare delivery through technology. The platform utilizes artificial intelligence and machine learning to analyze health records, facilitating video consultations between patients and doctors. By implementing innovative therapeutic modalities, Telelytics aims to improve access to appropriate care for individuals, enabling clinics to better serve their patients through smart scheduling and effective use-case matching.

Stroll, Inc. specializes in developing an integrated referral management application designed to enhance patient care by providing seamless access to healthcare services. The platform includes features such as automatic insurance verification, out-of-pocket cost estimates, clinical decision support, prior authorization, real-time scheduling, and patient reminders. By leveraging tools like real-time eligibility checks, insurance co-pay estimates, and quality metrics, Stroll enables patients to identify suitable care options based on their individual needs. The comprehensive patient engagement system ensures effective communication before, during, and after medical appointments, facilitating better preparation and follow-up. Stroll's innovative cloud image sharing technology and physician-specific analytics further streamline the sharing of medical information, addressing common challenges in the healthcare space related to compatibility and transparency. Founded in 2013 and based in San Francisco, California, Stroll aims to simplify the healthcare experience for both patients and providers.

Outcomes.com focuses on enhancing healthcare through technology by aligning incentives to promote data-driven care and improve patient outcomes. The company develops pharmacy management systems and clinical applications tailored for various healthcare settings, including assisted living and hospital pharmacies. Its platforms provide valuable insights and analytics, facilitate insurance claims processing, enable e-prescription connectivity, and streamline pharmacy workflow management. By offering these services, Outcomes.com aims to assist clients in optimizing operations, expanding their businesses, increasing patient engagement, and ultimately achieving better healthcare outcomes.

Lioness is a company focused on empowering women through innovative sexual wellness products. It develops an adaptive vibrator equipped with biometric sensors, designed to help women understand and take control of their bodies. This vibrator is paired with an application that allows users to visualize physiological responses and access a supportive community for personalized advice. By utilizing advanced technology, Lioness enables women to gain insights into their sexuality, including arousal patterns and optimal timing for sexual experiences. The company emphasizes a women-centric approach, with leadership and design choices reflecting the needs and preferences of women. By utilizing materials commonly used in medical devices and ergonomics tailored for comfort, Lioness aims to change the conversation surrounding female sexuality and provide valuable tools for self-discovery and empowerment.

Picosense is a technology company focused on transforming the heart monitoring industry through the development of a miniaturized, contact-less heart monitoring device. The company has created a millimeter-scale device that utilizes an innovative combination of Magnetoresistive (MR) sensors and Microelectromechanical (MEMS) resonators. This advanced integration allows for an unprecedented level of sensitivity in detecting low-frequency magnetic signals, while maintaining low power consumption, volume, and mass. Picosense's chip-scale sensors are specifically designed to measure picotesla magnetic signals, enabling accurate heart rate monitoring for patients.

Privail is a company focused on developing point-of-care diagnostics for the early detection of infectious diseases, with an initial emphasis on HIV. The company aims to create simple and affordable tests that empower patients to seek timely medical treatment, thereby improving their quality of life. Privail is comprised of a diverse team of scientists and engineers from the University of California, Berkeley, and the University of California, San Francisco, united by a shared mission to enhance healthcare access for underserved populations. The company also designs healthcare devices for tracking and detecting diseases, offering in-home testing solutions suitable for both developing and developed nations.

Zephyrus Biosciences, Inc. is a life science research tools company based in Berkeley, California, founded in 2013. The company specializes in developing and commercializing innovative tools for protein analysis at the single-cell level. Its flagship product, the scWestern System, allows for western blotting on individual cells, a significant advancement in the field of single-cell analysis. By utilizing microfluidics technology, the scWestern system partitions single cells into micro-wells, lyses them, and performs SDS-PAGE separation on each cell lysate. This technology facilitates the identification of cellular subpopulations, the analysis of enriched cell populations post-FACS sorting, and studies on cell signaling and cancer heterogeneity, among other applications. Researchers leverage Zephyrus's products to gain deeper insights into various biological fields, including cancer, stem cells, neurology, and human disease development, ultimately aiming to enhance healthcare outcomes.

Cortera Neurotechnologies, Inc. specializes in the design and development of implantable medical devices that focus on diagnosing and treating incurable neurological conditions. The company leverages over five years of expertise in NeuroEngineering to advance its innovative solutions within the neurodevices industry, which is valued at $4.5 billion. Cortera's wireless brain-machine devices are intended to enhance patient care and quality of life while also supporting advanced neuroscience research. By integrating circuit technology for brain sensing and stimulation, Cortera aims to provide medical professionals with cutting-edge tools to improve outcomes for individuals suffering from neurological disorders.

Crohnology is a patient-powered research platform designed to empower individuals with chronic medical conditions to contribute to research related to their own health. The company operates a patient-centered information-sharing network that connects patients, their families, and friends, fostering a collaborative environment for sharing health and treatment information. This platform enables users to engage with each other for social support while tracking and sharing their health experiences. By facilitating these connections, Crohnology aims to enhance the understanding and management of chronic conditions through collective patient insights.